CVKD vs. SNOW
CVKD (Cadrenal Therapeutics Inc. Common Stock) and SNOW (Snowflake Inc.) are both stocks. CVKD operates in Biotechnology (Healthcare), while SNOW operates in Software - Application (Technology). Over the past 3 years, CVKD returned -46.69%/yr vs 8.04%/yr for SNOW. At a 0.11 correlation, their price movements are largely independent.
Performance
CVKD vs. SNOW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVKD achieves a -48.38% return, which is significantly lower than SNOW's 5.89% return.
CVKD
- 1D
- 12.90%
- 1M
- -32.30%
- YTD
- -48.38%
- 6M
- -50.77%
- 1Y
- -71.66%
- 3Y*
- -46.69%
- 5Y*
- —
- 10Y*
- —
SNOW
- 1D
- -0.95%
- 1M
- 34.90%
- YTD
- 5.89%
- 6M
- 4.42%
- 1Y
- 9.58%
- 3Y*
- 8.04%
- 5Y*
- -1.41%
- 10Y*
- —
CVKD vs. SNOW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CVKD Cadrenal Therapeutics Inc. Common Stock | -48.38% | -53.21% | 30.56% | -87.04% |
SNOW Snowflake Inc. | 5.89% | 42.06% | -22.41% | 47.15% |
Correlation
The correlation between CVKD and SNOW is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jan 20, 2023 | 0.11 |
Fundamentals
CVKD:
$6.98M
SNOW:
$80.23B
CVKD:
-$5.10
SNOW:
-$3.53
CVKD:
2.55
SNOW:
38.93
CVKD:
$0.00
SNOW:
$5.03B
CVKD:
-$5.92K
SNOW:
$3.38B
CVKD:
-$13.32M
SNOW:
-$1.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVKD vs. SNOW — Risk / Return Rank
CVKD
SNOW
CVKD vs. SNOW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cadrenal Therapeutics Inc. Common Stock (CVKD) and Snowflake Inc. (SNOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVKD | SNOW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.89 | ||
| Sortino ratioReturn per unit of downside risk | -2.00 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.10 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | 0.17 | -1.11 |
| Martin ratioReturn relative to average drawdown | -1.75 | 0.37 | -2.12 |
Loading charts...
Drawdowns
CVKD vs. SNOW - Drawdown Comparison
The maximum CVKD drawdown since its inception was -96.45%, which is greater than SNOW's maximum drawdown of -72.99%. Use the drawdown chart below to compare losses from any high point for CVKD and SNOW.
Loading charts...
Drawdown Indicators
| CVKD | SNOW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.45% | -72.99% | -23.46% |
Max Drawdown (1Y)Largest decline over 1 year | -78.59% | -56.30% | -22.29% |
Max Drawdown (3Y)Largest decline over 3 years | -90.99% | -56.30% | -34.69% |
Max Drawdown (5Y)Largest decline over 5 years | — | -72.99% | — |
Current DrawdownCurrent decline from peak | -95.91% | -42.20% | -53.71% |
Average DrawdownAverage peak-to-trough decline | -84.76% | -49.00% | -35.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.27% | 26.01% | +16.26% |
Volatility
CVKD vs. SNOW - Volatility Comparison
The current volatility for Cadrenal Therapeutics Inc. Common Stock (CVKD) is 25.59%, while Snowflake Inc. (SNOW) has a volatility of 35.87%. This indicates that CVKD experiences smaller price fluctuations and is considered to be less risky than SNOW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVKD | SNOW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.59% | 35.87% | -10.28% |
Volatility (6M)Calculated over the trailing 6-month period | 68.05% | 52.67% | +15.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.95% | 65.44% | +34.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.22% | 61.91% | +40.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 102.22% | 62.61% | +39.61% |
Dividends
CVKD vs. SNOW - Dividend Comparison
Neither CVKD nor SNOW has paid dividends to shareholders.
Financials
CVKD vs. SNOW - Financials Comparison
This section allows you to compare key financial metrics between Cadrenal Therapeutics Inc. Common Stock and Snowflake Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CVKD and SNOW have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SNOW has higher volatility (35.87%) compared to CVKD (25.59%). In terms of maximum drawdown, CVKD dropped -96.45% vs SNOW's -72.99%.
SNOW currently has the higher Sharpe Ratio (0.15 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVKD and SNOW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer